Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 February 2020 | Story Xolisa Mnukwa | Photo Supplied
Student Counselling staff members
UFS SCD urges students to make use of the mental-health student toolkit to take control of their wellbeing and happiness and enjoy a compelling student life.

The University of the Free State’s (UFS) Student Counselling and Developmentnt (SCD) was recognised and applauded at the 2019 annual conference of the SSouthern African Association for Counselling and Development in Higher Education (SAACDHE), where they won the SAACDHE best region award for presenting the UFS Mental Health Student Toolkit at the conference, and for being active in the training and development of the UFS SCD team.

UFS Student Counselling and Development win at SAACDHE conference

The UFS, which was the only member institution of the Free State region, maintained vitality and relevance in the work they produced, competing against a number of student counselling centres in regions across South Africa, including KwaZulu-Natal, Western Cape, Eastern Cape, Vaal North-West, Gaunolanga Gauteng, Limpopo, Mpumalanga, Swaziland, and Botswana.

Students to take control of their wellbeing into their own hands

With the vision to promote, enable, and optimise students’ self-direction, the SCD launched the first edition of the student toolkit on Friday, 23 August 2019 – in an effort to assist students in coping with challenges they face in their personal lives during their period of study at the UFS. 

According to Counselling Psychologist in the SCD and compiler of the UFS Mental Health Student Toolkit, Lize Wolmarans, “The UFS Mental Health Student Toolkit is about putting the control of your wellbeing and happiness in your own hands. Taking responsibility for your mental health and understanding that it's the key to success in your personal, academic, and professional life as a student.” 

Dr Melissa Barnaschone, Director of the SCD, further explained that, “This is the culture our department wishes to instil in students – by building a holistic sense of wellbeing into life on campus. The toolkit was developed to empower students by providing increased access to mental-health resources and support.” 

“We have big plans for the toolkit, one of which is to develop it into an interactive app for students. This will enable students to interact with the information in more depth. Secondly, the toolkit will be expanded and adapted annually as we get feedback from students. We will add new relevant topics and continue to improve the overall layout and content. We are also able to learn very valuable information from the topics accessed online – we thus know which topics are the most/least relevant to our students,” Wolmarans added.

UFS Mental Health Student Toolkit a winning formula for student wellness

As a result of the exemplary methods of student counselling in the toolkit, a number of universities and institutions of higher education within South Africa have expressed interest in buying the toolkit to benchmark and prototype the effective student mental-health and wellbeing approaches portrayed in the toolkit.  Wolmarans further explained that, “This is South Africa’s first mental-health guide for university students, and other institutions recognised the potential advantages of purchasing a finished product instead of having to create their own toolkit.”

At the 2019 conference, Tobias van den Bergh, Counselling Psychologist at SCD (Qwaqwa Campus), was elected as Research, Training, and Development coordinator for SAACDHE.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept